TABLE 1.

Review eligibility criteria

PICO framework	Eligibility criteria
Population	Adults (≥18 years) with a non‐metastatic cancer, who have previously received or are receiving chemotherapy as part of their treatment. Studies were excluded if they included patients with: Metastatic cancer(s) or receiving chemotherapeutic agents palliatively. Dementia (preceding cancer diagnosis). Any mental health diagnosis (preceding cancer diagnosis). Primary central nervous system cancer(s).
Intervention	Any intervention targeted at improving chemotherapy‐related cognitive impairment.
Comparison	Studies with baseline measure of cognitive function. Studies with a control group for comparison.
Outcome	Studies empirically measuring cognitive function. Studies reporting patient‐reported objective and subjective cognitive function measures.